Article Impact Level: HIGH Data Quality: STRONG Summary of Genetics in Medicine https://doi.org/10.1016/j.gim.2026.102642 Dr. Sally Nijim et al.
Points
- Researchers led by Penn Medicine characterized seventy six international patients to define the genotypic and phenotypic spectra of TCF7L2-related neurodevelopmental disorder across fourteen countries.
- Key phenotypic findings included speech delay, autism, global developmental delays, vision problems such as nearsightedness, and orthopedic musculoskeletal issues among affected individuals.
- Distinct facial features were identified across the patient cohort, improving clinical recognition and diagnostic precision for this novel neurodevelopmental condition.
- Genetic analyses demonstrated wide symptom variability and suggested a potential association between specific TCF7L2 gene variants and adult-onset type two diabetes.
- Investigators established the TRND Network and opened a Simons Searchlight natural history study to collect longitudinal patient data and support therapeutic development.
Summary
This study evaluated the genotypic and phenotypic spectra of TCF7L2-related neurodevelopmental disorder (TRND), a rare condition caused by alterations in the TCF7L2 gene, which regulates essential pathways in early neurodevelopment. Published in Genetics in Medicine and co-led by researchers at the Perelman School of Medicine at the University of Pennsylvania, Mass General Brigham, and international collaborators, the investigation established the largest comprehensive characterization of TRND to date. The research sought to define core clinical manifestations, structural features, and genetic variations to improve diagnostic recognition and accelerate trial readiness.
The international cohort comprised 76 patients evaluated across 14 countries and multiple major clinical sites, including Philadelphia and Boston. Analysis revealed that primary phenotypic traits include speech delay, autism spectrum characteristics, global developmental delays, vision abnormalities such as myopia, and musculoskeletal or orthopedic complications. Additionally, patients presented with distinct dysmorphic facial features across varying stages of development. Genetic profiling demonstrated marked phenotypic variability and identified a potential association between specific TCF7L2 gene variants and adult-onset type 2 diabetes.
To expand longitudinal natural history data, researchers launched a Simons Searchlight registry study for active patient enrollment. The authors conclude that defining the genotypic and phenotypic parameters of TRND provides a critical diagnostic framework for clinicians, facilitates earlier detection through facial and developmental recognition, and establishes a foundation for longitudinal outcome tracking and targeted therapeutic development via the newly established TRND Network.
Link to the article: https://www.gimjournal.org/article/S1098-3600(26)00960-3/fulltext
References
Nijim, S., Kim, M., Denish, M., Gonzalez, M. V., Zinski, J., Rieubland, C., Braun, D., Ostergaard, E., Shillington, A., Faivre, L., Maraval, J., Garde, A., Philippe, C., Tran-Mau-Them, F., Crunk, A., Daber, R., Westheimer, E., O’Callaghan, W., Zhao, J., … Fajgenbaum, D. C. (2026). Characterization of the genotypic and phenotypic spectrum of TCF7L2-related neurodevelopmental disorder (Trnd). Genetics in Medicine, 28(10), 102642. https://doi.org/10.1016/j.gim.2026.102642
